TickerFactsScreenerDevelopers

GT Biopharma, Inc. (GTBP) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $1.29M2010: $54.0K2011: $92.0K2012: $123.0K2013: $43.0K2014: $855.0K2015: $47.0K2016: $19.0K2017: $576.0K2018: $60.0K2019: $28.0K2020: $5.30M2021: $8.97M2022: $5.67M2023: $1.08M2024: $3.95M2025: $6.81M$6.81M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$6.81M+72.4%
2024$3.95M+266.2%
2023$1.08M-81.0%
2022$5.67M-36.8%
2021$8.97M+69.3%
2020$5.30M+18817.9%
2019$28.0K-53.3%
2018$60.0K-89.6%
2017$576.0K+2931.6%
2016$19.0K-59.6%
2015$47.0K-94.5%
2014$855.0K+1888.4%
2013$43.0K-65.0%
2012$123.0K+33.7%
2011$92.0K+70.4%
2010$54.0K-95.8%
2009$1.29M—